To study the effect of Kushmanda Swarasa Bhavit haritaki churna in the management of Urdhvaga Amlapitta.

To evaluate the effect of kushmanda swarasa bhavit haritaki churna in the management of urdhwaga amlapitta. An open labelled single arm clinical study - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/12/098312

Enrollment

Registered

2025-12-02

Start date

Unknown

Completion date

Unknown

Last updated

2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K219- Gastro-esophageal reflux disease without esophagitis

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patient will be selected as per classical sign and symtoms of Urdhwaga Amlapitta Amlodgara, Hriddaha, Chardi. Mild and moderate patient of gastritis will be included.

Exclusion criteria

Exclusion criteria: Patient of Vidagdhajirna, Adhogamlapitta, Udara roga, Atikrush. Patient with severe vomiting and diarrhea. Patient of K/C/O hiatus hernia, Patient suffering from K/C/O chronic peptic ulcer or K/C/O duodenal ulcer. K/C/O Malignancy of stomach, Gall bladder stone. Patient having uncontrooled diabetes mellitus, uncontrolled hypothyroidism and hyperthyroidism hypertension. Pregnant and lactating females. Irritating poison, NSAID Induced gastritis. Severe gastritis.

Design outcomes

Primary

Measure	Time frame
Reduction in the symptoms of urdhwaga amlapitta Timepoint: 7 days	—

Secondary

Measure	Time frame
improvement in the symptoms of urdhwaga amlapitta Timepoint: 21 days	—

Countries

India

Contacts

Public ContactDr Dipti Purani

Government akhandanand ayurved college

diptipandya73@yahoo.in9427794040

Outcome results